Cargando…

Daytime polysomnography to perform titration for upper airway stimulation in patients with obstructive sleep apnea

PURPOSE: Upper airway stimulation (UAS) is an innovative treatment for patients with obstructive sleep apnea (OSA). UAS titrations are performed 3 months after activation of the device to optimize its effectiveness. In general, these titrations are performed during an in-laboratory overnight polysom...

Descripción completa

Detalles Bibliográficos
Autores principales: Bosschieter, Pien F. N., Schoustra, Emily, de Vries, Nico, Steinbusch, Meerie J. L., Kasius, Kristel M., Ravesloot, Madeline J. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316890/
https://www.ncbi.nlm.nih.gov/pubmed/34319499
http://dx.doi.org/10.1007/s11325-021-02441-w
_version_ 1783729959505756160
author Bosschieter, Pien F. N.
Schoustra, Emily
de Vries, Nico
Steinbusch, Meerie J. L.
Kasius, Kristel M.
Ravesloot, Madeline J. L.
author_facet Bosschieter, Pien F. N.
Schoustra, Emily
de Vries, Nico
Steinbusch, Meerie J. L.
Kasius, Kristel M.
Ravesloot, Madeline J. L.
author_sort Bosschieter, Pien F. N.
collection PubMed
description PURPOSE: Upper airway stimulation (UAS) is an innovative treatment for patients with obstructive sleep apnea (OSA). UAS titrations are performed 3 months after activation of the device to optimize its effectiveness. In general, these titrations are performed during an in-laboratory overnight polysomnography (PSG). However, overnight titrations are expensive and can be logistically challenging because they are labor-intensive which causes shortage of sleep technicians available for night shifts. In addition, recently, overnight PSGs were postponed and canceled due to the COVID-19 pandemic. We aimed to assess the feasibility of a daytime PSG to perform titration of UAS therapy as an alternative for a conventional overnight PSG. METHODS: We performed a prospective single-center observational cohort study. Patients were included when planned for UAS titration; this was approximately 6 months after UAS activation. Data on sleep architecture, patient experience, and respiratory outcomes were collected to evaluate the feasibility. An overnight follow-up PSG 12 months after implantation was used to compare sleep architecture and therapy response. RESULTS: Of 23 patients, four were excluded from analysis because of technical issues during PSG. Even though patients slept significantly shorter during the daytime PSG, this was enough time to complete the titration successfully with 30-min sleep in final therapeutic settings in 84% of the patients. Patients (94%) had a positive experience with the daytime titration. Respiratory outcomes were significantly reduced during titration and were maintained at the 12-month follow-up. CONCLUSION: Daytime titrations are a valuable alternative for conventional overnight titrations. Our findings suggest the implementation of daytime titrations as standard of care. This will contribute to easier logistics and better work circumstances for sleep technicians without jeopardizing titration quality.
format Online
Article
Text
id pubmed-8316890
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-83168902021-07-28 Daytime polysomnography to perform titration for upper airway stimulation in patients with obstructive sleep apnea Bosschieter, Pien F. N. Schoustra, Emily de Vries, Nico Steinbusch, Meerie J. L. Kasius, Kristel M. Ravesloot, Madeline J. L. Sleep Breath Sleep Breathing Physiology and Disorders • Original Article PURPOSE: Upper airway stimulation (UAS) is an innovative treatment for patients with obstructive sleep apnea (OSA). UAS titrations are performed 3 months after activation of the device to optimize its effectiveness. In general, these titrations are performed during an in-laboratory overnight polysomnography (PSG). However, overnight titrations are expensive and can be logistically challenging because they are labor-intensive which causes shortage of sleep technicians available for night shifts. In addition, recently, overnight PSGs were postponed and canceled due to the COVID-19 pandemic. We aimed to assess the feasibility of a daytime PSG to perform titration of UAS therapy as an alternative for a conventional overnight PSG. METHODS: We performed a prospective single-center observational cohort study. Patients were included when planned for UAS titration; this was approximately 6 months after UAS activation. Data on sleep architecture, patient experience, and respiratory outcomes were collected to evaluate the feasibility. An overnight follow-up PSG 12 months after implantation was used to compare sleep architecture and therapy response. RESULTS: Of 23 patients, four were excluded from analysis because of technical issues during PSG. Even though patients slept significantly shorter during the daytime PSG, this was enough time to complete the titration successfully with 30-min sleep in final therapeutic settings in 84% of the patients. Patients (94%) had a positive experience with the daytime titration. Respiratory outcomes were significantly reduced during titration and were maintained at the 12-month follow-up. CONCLUSION: Daytime titrations are a valuable alternative for conventional overnight titrations. Our findings suggest the implementation of daytime titrations as standard of care. This will contribute to easier logistics and better work circumstances for sleep technicians without jeopardizing titration quality. Springer International Publishing 2021-07-28 2022 /pmc/articles/PMC8316890/ /pubmed/34319499 http://dx.doi.org/10.1007/s11325-021-02441-w Text en © The Author(s), under exclusive licence to Springer Nature Switzerland AG 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Sleep Breathing Physiology and Disorders • Original Article
Bosschieter, Pien F. N.
Schoustra, Emily
de Vries, Nico
Steinbusch, Meerie J. L.
Kasius, Kristel M.
Ravesloot, Madeline J. L.
Daytime polysomnography to perform titration for upper airway stimulation in patients with obstructive sleep apnea
title Daytime polysomnography to perform titration for upper airway stimulation in patients with obstructive sleep apnea
title_full Daytime polysomnography to perform titration for upper airway stimulation in patients with obstructive sleep apnea
title_fullStr Daytime polysomnography to perform titration for upper airway stimulation in patients with obstructive sleep apnea
title_full_unstemmed Daytime polysomnography to perform titration for upper airway stimulation in patients with obstructive sleep apnea
title_short Daytime polysomnography to perform titration for upper airway stimulation in patients with obstructive sleep apnea
title_sort daytime polysomnography to perform titration for upper airway stimulation in patients with obstructive sleep apnea
topic Sleep Breathing Physiology and Disorders • Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316890/
https://www.ncbi.nlm.nih.gov/pubmed/34319499
http://dx.doi.org/10.1007/s11325-021-02441-w
work_keys_str_mv AT bosschieterpienfn daytimepolysomnographytoperformtitrationforupperairwaystimulationinpatientswithobstructivesleepapnea
AT schoustraemily daytimepolysomnographytoperformtitrationforupperairwaystimulationinpatientswithobstructivesleepapnea
AT devriesnico daytimepolysomnographytoperformtitrationforupperairwaystimulationinpatientswithobstructivesleepapnea
AT steinbuschmeeriejl daytimepolysomnographytoperformtitrationforupperairwaystimulationinpatientswithobstructivesleepapnea
AT kasiuskristelm daytimepolysomnographytoperformtitrationforupperairwaystimulationinpatientswithobstructivesleepapnea
AT raveslootmadelinejl daytimepolysomnographytoperformtitrationforupperairwaystimulationinpatientswithobstructivesleepapnea